Portable ultrasonic bone densitometer
By combining a portable ultrasonic bone densitometer with an ultrasonic probe and a drug delivery mechanism, and employing dual-transmitter, dual-receiver longitudinal emission technology and ultrasound-guided drug release, the problems of inconvenience in carrying and limited functionality have been solved, achieving high-precision detection and localized osteoporosis treatment.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHARACTERISTIC MEDICAL CENT OF THE CHINESE PEOPLES LIBERATION ARMY STRATEGIC SUPPORT FORCES
- Filing Date
- 2023-06-19
- Publication Date
- 2026-07-14
AI Technical Summary
Existing ultrasound bone densitometers are inconvenient to carry, have limited functionality, and cannot provide timely treatment based on test results.
A portable ultrasonic bone densitometer was designed, equipped with an ultrasonic probe, PCB controller, display screen and drug injection mechanism. It adopts dual-transmitter dual-receiver longitudinal emission technology for detection, and injects drugs into the human body through ultrasound guidance during the detection process to achieve ultrasound-responsive controlled release of drugs.
It achieves high-precision bone density testing, has a simple structure, is easy to carry, and is suitable for various environments. It can perform local bone enhancement treatment on fracture-prone areas during the testing process. It has multiple functions and is suitable for homes, medical institutions, and complex environments.
Smart Images

Figure CN116898481B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of medical device technology, and in particular to a portable ultrasonic bone densitometer. Background Technology
[0002] Human bone density peaks around age 30 and then gradually declines, leading to osteoporosis. Currently, my country has over 210 million people aged 60 and above, making it the country with the largest absolute number of elderly people in the world. With the increasingly serious aging population, osteoporosis has become one of the major diseases threatening the health and quality of life of Chinese residents, and is a public health problem urgently needing to be addressed. Osteoporosis patients have approximately a 40% lifetime risk of fracture. Furthermore, the medical treatment and care for osteoporosis and fractures require significant human, material, and financial resources, placing a heavy burden on families and society. Therefore, precise diagnosis and treatment of bone loss has significant social benefits. Current bone density tests and laboratory examinations can only reflect the overall bone calcium status of the body, and cannot accurately reflect the bone quality of key areas, nor can they enable timely treatment of fractures.
[0003] Patent CN103860203B discloses an integrated ultrasonic bone densitometer that embeds a tablet computer, color printer, ultrasonic probe, and drive controller into a single frame. This allows for ultrasonic signal detection, analysis, processing, and report printing, making it easy to operate and use. It is characterized by its small size and low power consumption, significantly reducing costs. However, the integrated ultrasonic bone densitometer disclosed in patent CN103860203B has multiple devices embedded in the frame, resulting in a complex structure that is difficult to adapt to various complex environments and is inconvenient to carry and transport. Furthermore, the ultrasonic bone densitometer only has a detection function and lacks ultrasonic-responsive controlled-release drug function, making it impossible to provide timely treatment based on test results. Its functionality is relatively limited, and it is inconvenient to use. Summary of the Invention
[0004] Therefore, the present invention aims to solve the problems of inconvenient carrying and transportation, limited functionality, and inconvenient use of existing ultrasonic bone densitometers.
[0005] Therefore, the technical solution adopted is that the present invention provides a portable ultrasonic bone densitometer, comprising: a housing, an ultrasonic probe disposed at one end of the housing, a PCB controller and an ultrasonic controller disposed inside the housing, a first USB interface and a display screen disposed on the outer wall of the housing, the PCB controller being electrically connected to the ultrasonic probe, the ultrasonic controller, the first USB interface and the display screen respectively, and the housing being electrically connected to a drug injection mechanism through the first USB interface.
[0006] Preferably, the drug injection mechanism includes: a drug tank and a drive pump.
[0007] The medicine compartment is equipped with a processor. A second USB interface is located on one side wall of the medicine compartment. One end of the drug delivery tube is connected to the medicine compartment, and the other end of the drug delivery tube is detachably equipped with an injection needle. The drug delivery tube is equipped with a drive pump and a flow control valve. The processor is electrically connected to the drive pump, the second USB interface, and the flow control valve. The second USB interface and the first USB interface are connected via a data cable.
[0008] Preferably, the medicine compartment is equipped with a liquid level sensor and a thermoelectric cooler, and the medicine delivery pipe is equipped with a one-way valve. The liquid level sensor and the thermoelectric cooler are electrically connected to the processor.
[0009] Preferably, a control panel is provided on one side wall of the display screen. The control panel is equipped with a power button, on / off switch, adjustment knob, indicator lights, etc., and the control panel is electrically connected to the PCB controller.
[0010] Preferably, a charging power supply is provided inside the housing, and a charging interface is provided on one side wall of the housing. The charging power supply is electrically connected to the PCB controller and the charging interface respectively.
[0011] Preferably, the housing contains a memory and a wireless communication component, and the PCB controller is electrically connected to the memory and the wireless communication component respectively.
[0012] Preferably, the medicine compartment is equipped with a drug injection auxiliary device, which includes: a transmission box,
[0013] A transmission box is installed on the inner wall at the bottom of the medicine storage compartment. An electric motor is installed on the inner wall at the bottom of the transmission box. The output shaft of the electric motor extends upward through the axis of the driving gear and connects to the sleeve of the transmission box. The output shaft of the electric motor is fixedly connected to the driving gear and rotatably connected to the top wall of the transmission box. Transmission rods are installed on both sides of the electric motor and rotatably connected to the inner wall at the bottom of the medicine storage compartment. A driven gear is installed at one end of the transmission rod and a crank is installed at the other end of the transmission rod. The driven gear and the driving gear mesh with each other.
[0014] Preferably, vertical support rods are provided on both sides of the motor, and guide rods are provided at the bottom of the support rods. Guide grooves extending axially are provided on the guide rods. The free end of the crank is rotatably connected to a first slider, which can reciprocate within the guide groove. An annular guide rail is provided above the transmission box, and the output shaft of the motor is located at the center of the annular guide rail. The top of the support rod extends out of the transmission box and connects to the bottom of the annular guide rail.
[0015] Preferably, the bottom edge of the U-shaped frame passes through the sleeve and is connected to one end of the L-shaped connecting rod. The U-shaped frame and the sleeve are rotatably connected. The other end of the L-shaped connecting rod is provided with a second slider, which can reciprocate within the annular guide rail. A connecting rod is provided on the top edge of the U-shaped frame, and fan plates are provided at both ends of the connecting rod.
[0016] Preferably, the top of the medicine compartment is provided with a medicine inlet, and the top of the medicine inlet is detachably provided with an end cap.
[0017] The technical solution of this invention has the following advantages:
[0018] The ultrasound probe of this invention adopts dual-transmitter, dual-receiver longitudinal transmission technology, and simultaneously obtains two equally spaced sound velocity values to indicate the parallelism between the ultrasound device and the bone being measured, thereby enabling detection of the human body with high accuracy and good repeatability. It can be used for real-time monitoring of bone mass at the target site.
[0019] This invention has a simple structure, small size, is easy to carry, and can be used in a variety of scenarios. It can be applied to simple environments such as homes and offices, as well as to medical institutions at all levels such as community hospitals, school hospitals, private clinics and rural health clinics in remote areas. It is also suitable for complex environments such as grassroots troops, aerospace and deep diving. It has strong universality and wide application range, and can establish a screening and follow-up system for osteoporosis in grassroots areas, remote areas and troops.
[0020] This invention is equipped with an injection mechanism that can inject drugs into the human body during ultrasound examination. Utilizing ultrasound positioning, drug-responsive release, and adjustable ultrasound power, ultrasound guides the release of drugs that inhibit bone resorption and promote bone formation at specific sites and time periods, thereby enhancing bone strength in key fracture-prone areas and achieving precise treatment of osteoporosis through ultrasound-responsive, time-segmented drug release with long-acting controlled release.
[0021] This invention has both the function of examining the human body and the function of local bone enhancement therapy. It can enhance the bone in areas of the human body that are prone to fractures, thereby treating osteoporosis in these areas and realizing the function of local bone enhancement therapy. It can be combined with systemic treatment to achieve integrated diagnosis and treatment of bone loss prevention, monitoring and treatment.
[0022] Other features and advantages of the invention will be set forth in the description which follows, and will be apparent in part from the description, or may be learned by practicing the invention. The objects and other advantages of the invention may be realized and obtained by means of the structures particularly pointed out in the written description, claims, and drawings.
[0023] The technical solution of the present invention will be further described in detail below with reference to the accompanying drawings and embodiments. Attached Figure Description
[0024] The accompanying drawings are provided to further illustrate the invention and form part of the specification. They are used in conjunction with embodiments of the invention to explain the invention and do not constitute a limitation thereof. In the drawings:
[0025] Figure 1 This is a schematic diagram of the structure of the present invention;
[0026] Figure 2 The image shown is a physical representation of the prior art of this invention.
[0027] Figure 3 This is a schematic diagram of the drug injection mechanism of the present invention;
[0028] Figure 4 This is a schematic diagram of the drug injection auxiliary device of the present invention;
[0029] Figure 5 This is a top view of the drug injection auxiliary device of the present invention;
[0030] Figure 6 This is a schematic diagram of the disinfection mechanism of the present invention;
[0031] Figure 7 This is a top view of the disinfection mechanism of the present invention;
[0032] The components are as follows: 1-House, 2-Ultrasonic probe, 3-PCB controller, 4-Ultrasonic controller, 5-First USB interface, 6-Display screen, 7-Drug compartment, 8-Drive pump, 9-Processor, 10-Second USB interface, 11-Drug infusion tube, 12-Injection needle, 13-Flow control valve, 14-Control panel, 15-Level sensor, 16-One-way valve, 17-Charging power supply, 18-Charging interface, 19-Memory, 20-Wireless communication component, 21-Transmission box, 22-Motor, 23-Annular guide rail, 24-U-shaped frame, 25-Drive gear, 26-Sleeve, 27-Transmission rod, 28-Driven gear. 29-Crank, 30-Support rod, 31-Guide rod, 32-Guide groove, 33-First slider, 34-L-shaped connecting rod, 35-Second slider, 36-Connecting rod, 37-Fan plate, 38-Drug inlet, 39-End cap, 40-Disinfection seat, 41-Cavity, 42-Opening, 43-Drive motor, 44-Annular slide rail, 45-First gear, 46-Connecting rod, 47-Rotating rod, 48-Second gear, 49-Cam, 50-Slot, 51-Rotating shaft, 52-Connecting rod, 53-Roller, 54-Mounting plate, 55-Reservoir, 56-Infusion tube, 57-Nozzle, 58-Drive pump, 59-Bristles. Detailed Implementation
[0033] To make the technical problems to be solved, the technical solutions and the beneficial effects of the present invention clearer, the preferred embodiments of the present invention will be described below with reference to the accompanying drawings. It should be understood that the preferred embodiments described herein are only for illustration and explanation of the present invention and are not intended to limit the present invention.
[0034] It should be noted that when a component is referred to as being "fixed to" or "set on" another component, it can be directly or indirectly attached to that other component. When a component is referred to as being "connected to" another component, it can be directly or indirectly connected to that other component.
[0035] It should be understood that the terms "length", "width", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", etc., indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings. They are only for the convenience of describing the present invention and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation. Therefore, they should not be construed as limitations on the present invention.
[0036] Furthermore, the terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of that feature. In the description of this invention, "a plurality of" means two or more, unless otherwise explicitly specified.
[0037] This invention provides a portable ultrasonic bone densitometer, such as... Figure 1-2 As shown, it includes: a housing 1, an ultrasonic probe 2 is provided at one end of the housing 1, a PCB controller 3 and an ultrasonic controller 4 are provided inside the housing 1, a first USB interface 5 and a display screen 6 are provided on the outer wall of the housing 1, the PCB controller 3 is electrically connected to the ultrasonic probe 2, the ultrasonic controller 4, the first USB interface 5 and the display screen 6 respectively, and the housing 1 is electrically connected to the drug injection mechanism through the first USB interface 5.
[0038] The working principle of the above technical solution is as follows: The ultrasonic probe 2 uses the sound wave propagation speed and amplitude attenuation to reflect the bone mineral content, bone structure and bone strength. It adopts dual-transmitter and dual-receiver longitudinal transmission technology to simultaneously obtain two equally spaced sound velocity values to indicate the parallel state between the ultrasonic device and the bone being tested, and to detect the human skeleton. The ultrasonic controller 4 controls the ultrasonic intensity of the ultrasonic probe 2, and the display screen 6 displays the detection image of the ultrasonic probe 2. The drug injection mechanism injects ultrasonic responsive drug-loaded microbubbles into the human body according to the detection results of the ultrasonic probe 2. The injection process is realized under the guidance of the ultrasonic probe 2. The cavitation effect of ultrasound is used to increase the ultrasonic intensity to destroy the microbubbles and form a local release of the drug. The PCB controller 3 controls the operation of each device.
[0039] The beneficial effects of the above technical solution are as follows:
[0040] The ultrasonic probe of this invention adopts dual-transmitter, dual-receiver longitudinal transmission technology, and simultaneously obtains two equally spaced sound velocity values to indicate the parallelism between the ultrasonic device and the bone being measured. It has high detection accuracy and good repeatability, and can be used for real-time monitoring of bone volume at the target site.
[0041] This invention has a simple structure, small size, is easy to carry, and can be used in a variety of scenarios. It can be applied to simple environments such as homes and offices, as well as to medical institutions at all levels such as community hospitals, school hospitals, private clinics and rural health clinics in remote areas. It is also suitable for complex environments such as grassroots troops, aerospace and deep diving. It has strong universality and wide application range, and can establish a screening and follow-up system for osteoporosis in grassroots areas, remote areas and troops.
[0042] This invention is equipped with an injection mechanism that can inject drugs into the human body during ultrasound examination. Utilizing ultrasound positioning, drug-responsive release, and adjustable ultrasound power, ultrasound guides the release of drugs that inhibit bone resorption and promote bone formation at specific sites and time periods, thereby enhancing bone strength in key fracture-prone areas and achieving precise treatment of osteoporosis through ultrasound-responsive, time-segmented drug release with long-acting controlled release.
[0043] This invention has both the function of examining the human body and the function of local bone enhancement therapy. It can be combined with systemic treatment to achieve integrated diagnosis and treatment of bone loss prevention, monitoring and treatment.
[0044] In one embodiment, such as Figure 3 As shown, the drug injection mechanism includes: a drug reservoir 7 and a drive pump 8.
[0045] The medicine compartment 7 is equipped with a processor 9. A second USB interface 10 is provided on one side wall of the medicine compartment 7. One end of the drug delivery tube 11 is connected to the medicine compartment 7, and the other end of the drug delivery tube 11 is detachably equipped with an injection needle 12. A drive pump 8 and a flow control valve 13 are provided on the drug delivery tube 11. The processor 9 is electrically connected to the drive pump 8, the second USB interface 10, and the flow control valve 13 respectively. The second USB interface 10 and the first USB interface 5 are connected by a data cable.
[0046] The working principle and beneficial effects of the above technical solution are as follows: The injectable drug is composed of injectable ultrasound-responsive drug-loaded microbubbles and thermosensitive hydrogel. When the drug needs to be injected, the PCB controller 3 starts the processor 9 through the first USB interface 5 and the second USB interface 10 according to the detection results of the ultrasound probe 2. The processor 9 starts the drive pump 8, which injects the drug in the drug tank 7 into the human body through the drug delivery tube 11 and the injection needle 12. The processor 9 starts the flow control valve 13 according to the detection results of the ultrasound probe 2 fed back by the PCB controller 3 in real time, and adjusts the flow rate in the drug delivery tube 11 to adjust the injection speed and injection volume of the drug into the human body, so as to achieve controllable injection.
[0047] In one embodiment, a liquid level sensor 15 and a thermoelectric cooler are provided in the medicine tank 7, and a one-way valve 16 is provided on the medicine delivery pipe 11. The liquid level sensor 15 and the thermoelectric cooler are electrically connected to the processor 9.
[0048] The working principle and beneficial effects of the above technical solution are as follows: the liquid level sensor 15 is used to detect the amount of medicine in the medicine tank 7, thereby determining the amount of medicine injected into the human body, and at the same time facilitating timely replenishment of medicine in the medicine tank 7; the one-way valve 16 is used to prevent the medicine in the infusion tube 11 from flowing back into the medicine tank 7, avoiding contamination of the medicine in the medicine tank 7; the semiconductor cooling chip is used to reduce the temperature in the medicine tank 7, preventing the medicine in the medicine tank 7 from becoming ineffective due to high temperature.
[0049] In one embodiment, a control panel 14 is provided on one side wall of the display screen 6. The control panel 14 is provided with a power button, an on / off switch, an adjustment knob, an indicator light, etc., and the control panel 14 is electrically connected to the PCB controller 3.
[0050] The working principle and beneficial effects of the above technical solution are as follows: the control panel 14 is used to control the operation of the ultrasonic bone densitometer, the power button is used to turn the ultrasonic bone densitometer on or off, the on / off switch is used to start or stop the ultrasonic bone densitometer during use, the adjustment knob is used to adjust the ultrasonic controller 4, thereby adjusting the ultrasonic intensity of the ultrasonic probe 2, and the indicator light is used to indicate the operating status of the ultrasonic bone densitometer.
[0051] In one embodiment, a charging power supply 17 is provided inside the housing 1, and a charging interface 18 is provided on one side wall of the housing 1. The charging power supply 17 is electrically connected to the PCB controller 3 and the charging interface 18 respectively.
[0052] The working principle and beneficial effects of the above technical solution are as follows: the charging power supply 17 is used to supply power to the various devices inside the housing 1. The charging power supply 17 is connected to an external power source through the charging interface 18, thereby charging the charging power supply 17.
[0053] In one embodiment, a memory 19 and a wireless communication component 20 are provided inside the housing 1, and the PCB controller 3 is electrically connected to the memory 19 and the wireless communication component 20 respectively.
[0054] The working principle and beneficial effects of the above technical solution are as follows: the memory 19 is used to store the image information detected by the ultrasound probe 2, which is convenient for doctors to continue to view; the wireless communication component 20 is wirelessly connected to the external control system, and the control system realizes remote control of the ultrasound bone densitometer.
[0055] In one embodiment, such as Figure 4-5 As shown, the medicine compartment 7 is equipped with a medicine injection auxiliary device, which includes: a transmission box 21.
[0056] A transmission box 21 is provided on the inner wall of the bottom end of the medicine storage 7. A motor 22 is provided on the inner wall of the bottom end of the transmission box 21. The output shaft of the motor 22 extends upward through the axis of the drive gear 25 and out of the transmission box 21 to connect with the sleeve 26. The output shaft of the motor 22 is fixedly connected to the drive gear 25 and rotatably connected to the top wall of the transmission box 21. Transmission rods 27 are provided on both sides of the motor 22. The transmission rods 27 are rotatably connected to the inner wall of the bottom end of the medicine storage 7. A driven gear 28 is provided at one end of the transmission rod 27 and a crank 29 is provided at the other end of the transmission rod 27. The driven gear 28 meshes with the drive gear 25.
[0057] Vertical support rods 30 are provided on both sides of the motor 22. A guide rod 31 is provided at the bottom of the support rod 30. A guide groove 32 extending axially is provided on the guide rod 31. The free end of the crank 29 is rotatably connected to the first slider 33. The first slider 33 can reciprocate within the guide groove 32. An annular guide rail 23 is provided above the transmission box 21. The output shaft of the motor 22 is located at the center of the annular guide rail 23. The top of the support rod 30 extends out of the transmission box 21 and connects to the bottom of the annular guide rail 23.
[0058] The bottom frame of the U-shaped frame 24 passes through the sleeve 26 and is connected to one end of the L-shaped connecting rod 34. The U-shaped frame 24 and the sleeve 26 are rotatably connected. The other end of the L-shaped connecting rod 34 is provided with a second slider 35, which can reciprocate within the annular guide rail 23. The top frame of the U-shaped frame 24 is provided with a connecting rod 36, and the two ends of the connecting rod 36 are respectively provided with fan plates 37.
[0059] The working principle and beneficial effects of the above technical solution are as follows: When an injectable drug composed of injectable ultrasound-responsive drug-loaded microbubbles and thermosensitive hydrogel is added to the drug tank 7, the motor 22 is started, driving the drive gear 25 and the sleeve 26 to rotate. Through the gear meshing transmission between the drive gear 25 and the driven gear 28, the driven gear 28 is driven to rotate, driving the transmission rod 27 and the crank 29 to rotate, driving the first slider 33 to rotate around the transmission rod 27, causing the first slider 33 to reciprocate in the guide groove 32, driving the guide rod 31 and the support rod 30 to reciprocate up and down, driving the annular guide rail 23 to reciprocate up and down; the sleeve 26 drives the U-shaped frame 24 to rotate, driving the L-shaped connecting rod 34 to rotate around the output shaft of the motor 22, causing the second slider 35 to move around the output shaft of the motor 22 in the annular guide rail 23. Through the superposition of the combined motion, the second slider 35 moves in... The annular guide rail 23 rotates around the output shaft of the motor 22 while reciprocating up and down. The second slider 35 drives the U-shaped frame 24 to swing around its bottom edge while rotating around the output shaft of the motor 22. This drives the connecting rod 36 and the fan plate 37 to swing around the bottom edge of the U-shaped frame 24 while rotating around the output shaft of the motor 22. The connecting rod 36 and the fan plate 37 agitate the mixture of injectable ultrasound-responsive drug-loaded microbubbles and thermosensitive hydrogel, ensuring uniform mixing and preventing segregation or coagulation of the drug due to prolonged storage or complex external environmental influences, which could affect the drug injection effect and avoid harm to the human body. Simultaneously, after the drug injection is completed, cleaning solution is added to the drug chamber 7, and the drug injection auxiliary device is activated to agitate the cleaning solution in the drug chamber 7, cleaning the inner wall of the drug chamber 7 to prevent drug residue from affecting the next injection, improving the cleaning effect, and enhancing the safety of drug injection.
[0060] In one embodiment, the top of the medicine compartment 7 is provided with a medicine inlet 38, and the top of the medicine inlet 38 is detachably provided with an end cap 39.
[0061] The working principle and beneficial effects of the above technical solution are as follows: injectable drugs are added into the drug chamber 7 through the drug inlet 38, and the end cap 39 is used to seal the drug inlet 38 to prevent the drugs in the drug chamber 7 from being contaminated.
[0062] In one embodiment, such as Figure 6-7 As shown, it also includes a disinfection mechanism, which comprises: a disinfection seat 40, a cavity 41, an opening 42, and a drive motor 43.
[0063] The sterilization seat 40 has a cavity 41 inside. The top of the sterilization seat 40 has an opening 42 that communicates with the cavity 41. One end of the housing 1 with an ultrasonic probe 2 can pass through the opening 42 and be inserted into the cavity 41. The housing 1 and the opening 42 are snapped together. The bottom inner wall of the cavity 41 is provided with a drive motor 43 and an annular slide rail 44. The drive motor 43 is located at the center of the annular slide rail 44. The output shaft of the drive motor 43 passes upward through the axis of the first gear 45 and is connected to the middle of the connecting rod 46. The output shaft of the drive motor 43 is fixedly connected to the first gear 45. A vertical rotating rod 47 is provided on one side of the drive motor 43. The bottom end of the rotating rod 47 is rotatably connected to the bottom inner wall of the cavity 41. The top end of the rotating rod 47 is provided with a second gear 48. The top end of the second gear 48 is provided with a cam 49. A slot 50 is provided on one side of the annular slide rail 44. The drive motor 43, the rotating rod 47 and the slot 50 are coaxial.
[0064] Rotating rod 47 is rotatably connected to two ends of rotating shaft 51. A connecting rod 52 is provided at the bottom end of rotating shaft 51 passing through rotating rod 47. Rollers 53 are rotatably connected to both ends of connecting rod 52. Rollers 53 can move on annular slide rail 44. A mounting plate 54 is provided at the top of rotating shaft 51. Several ultraviolet disinfection lamps are provided on one outer wall of mounting plate 54. A liquid storage tank 55 is provided on the other outer wall of mounting plate 54. One end of infusion tube 56 is connected to liquid storage tank 55. A nozzle 57 is provided at the other end of infusion tube 56. A drive pump 58 is provided on infusion tube 56. Several bristles 59 are provided around liquid storage tank 55. Several ultraviolet disinfection lamps are provided at the top of connecting rod 46. Several bristles 59 are provided between ultraviolet disinfection lamps.
[0065] The working principle and beneficial effects of the above technical solution are as follows: After the ultrasonic bone densitometer is used, the ultrasonic probe 2 is inserted into the cavity 41 through the opening 42, and the housing 1 is snapped into the opening 42. In the initial state, the side of one mounting plate 54 with the liquid storage tank 55 facing the housing 1, and the side of the other mounting plate 54 with the ultraviolet disinfection lamp facing the housing 1. The drive pump 58 is started, and the disinfectant in the liquid storage tank 55 is pumped to the nozzle 57 through the infusion pipe 56 to clean the frustum side wall of the housing 1 where the ultrasonic probe 2 is installed. The ultraviolet disinfection lamp is then activated. The toxic lamp irradiates and disinfects the housing 1; the drive motor 43 is started, driving the first gear 45 and the connecting rod 46 to rotate. Through the gear meshing between the first gear 45 and the second gear 48, the second gear 48, the rotating rod 47, and the cam 49 are driven to rotate. The connecting rod 46 drives the rotating shaft 51, the connecting rod 52, and the roller 53 to rotate around the drive motor 43, so that the roller 53 rotates around the drive motor 43 on the annular slide rail 44. When the roller 53 at one end of the connecting rod 52 moves to the slot 50, the cam 49 also rotates to the slot 50. 49. Pushing the first roller 53 into the slot 50 causes the connecting rod 52 to rotate around the rotating shaft 51, causing the mounting plate 54 to flip. The ultraviolet disinfection lamp on the other side of the mounting plate 54 irradiates and disinfects the frustum sidewall of the housing 1 where the ultrasonic probe 2 is mounted. Through the superposition of motion, the two mounting plates 54 rotate around the drive motor 43 while flipping intermittently. The two mounting plates 54 flip alternately, that is, while one mounting plate 54 is cleaning the housing 1, the other mounting plate 54 is irradiating and disinfecting the housing 1, thus improving the disinfection efficiency; around the liquid storage tank 55 The bristles 59 clean the side wall of the housing 1 and, together with the disinfectant, clean the side wall of the housing 1 to improve the disinfection effect. The connecting rod 46 drives the ultraviolet disinfection lamp on it to rotate and irradiate the ultrasonic probe 2 for disinfection. The connecting rod 46 drives the bristles 59 on it to clean the ultrasonic probe 2, removing dust and impurities from the surface of the ultrasonic probe 2 and ensuring that the surface of the ultrasonic probe 2 is clean. The disinfectant sprayed from the nozzle 57 falls on the surface of the bristles 59 on the connecting rod 46. The bristles 59 carrying the disinfectant brush the surface of the ultrasonic probe 2 for cleaning and disinfection, making it convenient for the next use.
[0066] In one embodiment, the disinfection seat 40 is provided with a removable liquid collection tank, which is connected to the cavity 41 to facilitate the collection of disinfectant sprayed from the nozzle 57.
[0067] Obviously, those skilled in the art can make various modifications and variations to this invention without departing from its spirit and scope. Therefore, if these modifications and variations fall within the scope of the claims of this invention and their equivalents, this invention also intends to include these modifications and variations.
Claims
1. A portable ultrasonic bone densitometer, characterized in that, The ultrasonic bone densitometer includes a main body and a drug injection mechanism. The main body of the ultrasonic bone densitometer includes a housing (1), an ultrasonic probe (2) is provided at one end of the housing (1), a PCB controller (3) and an ultrasonic controller (4) are provided inside the housing (1), a first USB interface (5) and a display screen (6) are provided on the outer wall of the housing (1), the PCB controller (3) is electrically connected to the ultrasonic probe (2), the ultrasonic controller (4), the first USB interface (5) and the display screen (6) respectively, and the main body of the ultrasonic bone densitometer is electrically connected to the drug injection mechanism through the first USB interface (5). The drug dispensing mechanism includes: a drug tank (7) and a drive pump (8). A processor (9) is installed inside the medicine compartment (7). A second USB interface (10) is installed on one side wall of the medicine compartment (7). One end of the drug delivery tube (11) is connected to the medicine compartment (7). An injection needle (12) is detachably installed on the other end of the drug delivery tube (11). A drive pump (8) and a flow control valve (13) are installed on the drug delivery tube (11). The processor (9) is electrically connected to the drive pump (8), the second USB interface (10), and the flow control valve (13) respectively. The second USB interface (10) and the first USB interface (5) are connected by a data cable. The medicine compartment (7) is equipped with a drug injection auxiliary device, which includes a transmission box (21). A transmission box (21) is installed on the inner wall of the bottom end of the medicine storage (7). A motor (22) is installed on the inner wall of the bottom end of the transmission box (21). The output shaft of the motor (22) extends upward through the axis of the driving gear (25) and out of the transmission box (21) and connects to the sleeve (26). The output shaft of the motor (22) is fixedly connected to the driving gear (25) and rotatably connected to the top wall of the transmission box (21). Transmission rods (27) are respectively installed on both sides of the motor (22). The transmission rods (27) are rotatably connected to the inner wall of the bottom end of the medicine storage (7). A driven gear (28) is installed at one end of the transmission rod (27), and a crank (29) is installed at the other end of the transmission rod (27). The driven gear (28) meshes with the driving gear (25). Vertical support rods (30) are respectively installed on both sides of the motor (22). A guide rod (31) is installed at the bottom end of the support rod (30). The transmission box (21) is provided with a guide groove (32) extending along the axial direction. The free end of the crank (29) is rotatably connected to the first slider (33). The first slider (33) can reciprocate within the guide groove (32). A ring guide rail (23) is provided above the transmission box (21). The output shaft of the motor (22) is located at the center of the ring guide rail (23). The top end of the support rod (30) extends out of the transmission box (21) and connects to the bottom end of the ring guide rail (23). The bottom frame of the U-shaped frame (24) passes through the sleeve (26) and is connected to one end of the L-shaped connecting rod (34). The U-shaped frame (24) is rotatably connected to the sleeve (26). The other end of the L-shaped connecting rod (34) is provided with a second slider (35). The second slider (35) can reciprocate within the ring guide rail (23). A connecting rod (36) is provided on the top frame of the U-shaped frame (24). Fan plates (37) are provided at both ends of the connecting rod (36).
2. A portable ultrasonic bone densitometer as described in claim 1, characterized in that, The medicine compartment (7) is equipped with a liquid level sensor (15) and a semiconductor cooling chip, and a one-way valve (16) is installed on the medicine delivery pipe (11). The liquid level sensor (15) and the semiconductor cooling chip are electrically connected to the processor (9).
3. A portable ultrasonic bone densitometer as described in claim 1, characterized in that, A control panel (14) is provided on one side wall of the display screen (6). The control panel (14) is equipped with a power button, an on / off switch, an adjustment knob, and an indicator light. The control panel (14) is electrically connected to the PCB controller (3).
4. A portable ultrasonic bone densitometer as described in claim 1, characterized in that, A charging power supply (17) is provided inside the housing (1), and a charging interface (18) is provided on one side wall of the housing (1). The charging power supply (17) is electrically connected to the PCB controller (3) and the charging interface (18) respectively.
5. A portable ultrasonic bone densitometer as described in claim 1, characterized in that, The housing (1) contains a memory (19) and a wireless communication component (20), and the PCB controller (3) is electrically connected to the memory (19) and the wireless communication component (20) respectively.
6. A portable ultrasonic bone densitometer as described in claim 1, characterized in that, The top of the medicine container (7) is provided with a medicine inlet (38), and the top of the medicine inlet (38) is detachably provided with an end cap (39).